Literature DB >> 2721916

The serotype distribution of Campylobacter in patients with diarrhoea in Kuwait.

E Sjögren1, M Johny, B Kaijser.   

Abstract

Fifty one strains of Campylobacter jejuni/coli isolated from patients with diarrhoea, at the Amiri Hospital, Hawally, Kuwait were classified on the basis of the heatstable-HS-antigens and the heat-labile-HL-antigens, by using 20 and 23 hyperimmune antisera for the two methods, respectively. The ages of the patient ranged from 3 months to 60 years, and 72.6% of the strains were from children less than 4 years. With the number of antisera used 78.4% of the HS antigens and 96.1% of the HL antigens could be identified. About half of the strains had one of five HS antigens (4, 8, 13, 5 or 25) and 70.5% of the strains had one of five HL antigens (1, 36, 2, 6, or 21). The study shows that the most common HS and HL antigens among Campylobacter strains from Kuwait also are the most frequent antigens of strains from other parts of the world. A limited number of antisera are sufficient to identify the majority of the strains.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2721916     DOI: 10.1111/j.1574-6968.1989.tb03306.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  6 in total

1.  Evaluation of commercial antisera for serotyping heat-labile antigens of Campylobacter jejuni and Campylobacter coli.

Authors:  M A Nicholson; C M Patton
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

2.  Common somatic O and heat-labile serotypes among Campylobacter strains from sporadic infections in the United States.

Authors:  C M Patton; M A Nicholson; S M Ostroff; A A Ries; I K Wachsmuth; R V Tauxe
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

3.  In vitro binding of Campylobacter jejuni/coli outer membrane preparations to INT 407 cell membranes.

Authors:  I Moser; W F Schröder; E Hellmann
Journal:  Med Microbiol Immunol       Date:  1992       Impact factor: 3.402

4.  Capsule polysaccharide conjugate vaccine against diarrheal disease caused by Campylobacter jejuni.

Authors:  Mario A Monteiro; Shahida Baqar; Eric R Hall; Yu-Han Chen; Chad K Porter; David E Bentzel; Lisa Applebee; Patricia Guerry
Journal:  Infect Immun       Date:  2008-12-29       Impact factor: 3.441

Review 5.  Global Distribution of Campylobacter jejuni Penner Serotypes: A Systematic Review.

Authors:  Brian L Pike; Patricia Guerry; Frédéric Poly
Journal:  PLoS One       Date:  2013-06-27       Impact factor: 3.240

Review 6.  Campylobacter polysaccharide capsules: virulence and vaccines.

Authors:  Patricia Guerry; Frédéric Poly; Mark Riddle; Alexander C Maue; Yu-Han Chen; Mario A Monteiro
Journal:  Front Cell Infect Microbiol       Date:  2012-02-15       Impact factor: 5.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.